ArticleIn vivo (Athens, Greece)

Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib.

Naoki Fukuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.